The Europe Wound Management Devices Market is expected to witness market growth of 6.8% CAGR during the forecast period (2020-2026).
A chronic wound is categorized as a wound that shows no substantial progress in 30 days and doesn't show any progress through the stages of healing in a systematic and timely sequence. On the other hand, acute wounds are classified as a wound that shows healing through the routine process of inflammation, tissue formation, and remodeling, in a shorter time frame. Advanced wound care products are formulated exclusively for the treatment of chronic and acute wounds. The advanced wound care products include advanced wound dressings, wound care devices like NPWT, and active wound care therapies like skin grafts and substitutes.
In the healthcare industry, the treatment of chronic and acute wounds is increasing the economic burden in various countries. However, the development in the health care industry has led to cost-effective and innovative care products for the patient. With an increasing demand for health care products estimated to increase the cost of treatment.
Each year, the economic cost for the treatment of venous leg ulcers and pressure ulcers in the country is anticipated to increase. Companies are continuously making an effort to launch new and advanced products for chronic wounds, with a motive to offer cost-effective treatment to a substantial pool of elderly patients.
Based on Product, the market is segmented into Therapy Devices, Wound closure Devices and Other Products. Based on Application, the market is segmented into Burns, Pressure Ulcers, Diabetic Foot Ulcers, Surgical Wounds and Other Applications. Based on End User, the market is segmented into Clinics, Hospitals and Other End User. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Baxter International, Inc., Coloplast Group, ConvaTec Group PLC, Integra LifeSciences Holdings Corporation (Derma Sciences, Inc.), Johnson and Johnson, 3M Company, Medtronic PLC, Smith & Nephew PLC, Hollister, Inc., and Molnlycke Health Care AB.
Scope of the Study
Market Segmentation:
By Product
By Application
By End User
By Country
Companies Profiled
Unique Offerings from the Publisher
A chronic wound is categorized as a wound that shows no substantial progress in 30 days and doesn't show any progress through the stages of healing in a systematic and timely sequence. On the other hand, acute wounds are classified as a wound that shows healing through the routine process of inflammation, tissue formation, and remodeling, in a shorter time frame. Advanced wound care products are formulated exclusively for the treatment of chronic and acute wounds. The advanced wound care products include advanced wound dressings, wound care devices like NPWT, and active wound care therapies like skin grafts and substitutes.
In the healthcare industry, the treatment of chronic and acute wounds is increasing the economic burden in various countries. However, the development in the health care industry has led to cost-effective and innovative care products for the patient. With an increasing demand for health care products estimated to increase the cost of treatment.
Each year, the economic cost for the treatment of venous leg ulcers and pressure ulcers in the country is anticipated to increase. Companies are continuously making an effort to launch new and advanced products for chronic wounds, with a motive to offer cost-effective treatment to a substantial pool of elderly patients.
Based on Product, the market is segmented into Therapy Devices, Wound closure Devices and Other Products. Based on Application, the market is segmented into Burns, Pressure Ulcers, Diabetic Foot Ulcers, Surgical Wounds and Other Applications. Based on End User, the market is segmented into Clinics, Hospitals and Other End User. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Baxter International, Inc., Coloplast Group, ConvaTec Group PLC, Integra LifeSciences Holdings Corporation (Derma Sciences, Inc.), Johnson and Johnson, 3M Company, Medtronic PLC, Smith & Nephew PLC, Hollister, Inc., and Molnlycke Health Care AB.
Scope of the Study
Market Segmentation:
By Product
- Therapy Devices
- Wound closure Devices and
- Other Products
By Application
- Burns
- Pressure Ulcers
- Diabetic Foot Ulcers
- Surgical Wounds and
- Other Applications
By End User
- Clinics
- Hospitals and
- Other End User
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Companies Profiled
- Baxter International, Inc.
- Coloplast Group
- ConvaTec Group PLC
- Integra LifeSciences Holdings Corporation (Derma Sciences, Inc.)
- Johnson and Johnson
- 3M Company
- Medtronic PLC
- Smith & Nephew PLC
- Hollister, Inc.
- Molnlycke Health Care AB
Unique Offerings from the Publisher
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. Europe Wound Management Devices Market by Product
Chapter 5. Europe Wound Management Devices Market by Application
Chapter 6. Europe Wound Management Devices Market by End User
Chapter 7. Europe Wound Management Devices Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Baxter International, Inc.
- Coloplast Group
- ConvaTec Group PLC
- Integra LifeSciences Holdings Corporation (Derma Sciences, Inc.)
- Johnson and Johnson
- 3M Company
- Medtronic PLC
- Smith & Nephew PLC
- Hollister, Inc.
- Molnlycke Health Care AB
Methodology
LOADING...
